3/30
06:21 am
xncr
Xencor (XNCR) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Low
Report
Xencor (XNCR) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
3/24
08:30 am
xncr
Xencor (XNCR) had its "neutral" rating reaffirmed by JPMorgan Chase & Co.. They now have a $13.00 price target on the stock, down from $18.00.
Low
Report
Xencor (XNCR) had its "neutral" rating reaffirmed by JPMorgan Chase & Co.. They now have a $13.00 price target on the stock, down from $18.00.
3/5
10:17 am
xncr
Xencor falls as royalty dispute with Astra leads to guidance cut [Seeking Alpha]
Low
Report
Xencor falls as royalty dispute with Astra leads to guidance cut [Seeking Alpha]
3/4
04:28 pm
xncr
Xencor Announces Change to Ultomiris® Royalty Revenue Forecast [Yahoo! Finance]
High
Report
Xencor Announces Change to Ultomiris® Royalty Revenue Forecast [Yahoo! Finance]
3/4
04:01 pm
xncr
Xencor Announces Change to Ultomiris® Royalty Revenue Forecast
High
Report
Xencor Announces Change to Ultomiris® Royalty Revenue Forecast
2/28
01:30 am
xncr
Medium
Report
2/26
10:30 am
xncr
Xencor (XNCR) had its price target raised by Barclays PLC from $26.00 to $27.00. They now have an "overweight" rating on the stock.
Low
Report
Xencor (XNCR) had its price target raised by Barclays PLC from $26.00 to $27.00. They now have an "overweight" rating on the stock.
2/25
04:01 pm
xncr
Xencor Reports Fourth Quarter and Full Year 2025 Financial Results
High
Report
Xencor Reports Fourth Quarter and Full Year 2025 Financial Results
2/23
04:03 pm
xncr
Xencor to Participate at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Xencor to Participate at Upcoming Investor Conferences [Yahoo! Finance]
2/23
04:01 pm
xncr
Xencor to Participate at Upcoming Investor Conferences
Low
Report
Xencor to Participate at Upcoming Investor Conferences
2/8
06:51 pm
xncr
What Catalysts Are Rewriting The Xencor (XNCR) Story In A Recovering Biopharma Sector [Yahoo! Finance]
Low
Report
What Catalysts Are Rewriting The Xencor (XNCR) Story In A Recovering Biopharma Sector [Yahoo! Finance]
1/30
12:53 am
xncr
Xencor (XNCR): BofA Bullish on US Biopharmaceuticals Coverage [Yahoo! Finance]
Medium
Report
Xencor (XNCR): BofA Bullish on US Biopharmaceuticals Coverage [Yahoo! Finance]
1/19
01:53 am
xncr
Xencor (XNCR) Valuation Check After New Oncology And Autoimmune Pipeline Milestones [Yahoo! Finance]
Low
Report
Xencor (XNCR) Valuation Check After New Oncology And Autoimmune Pipeline Milestones [Yahoo! Finance]
1/8
08:01 am
xncr
Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones
Medium
Report
Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones
1/5
10:25 am
xncr
Incyte marks late-stage trial win for Xencor-partnered lymphoma therapy [Seeking Alpha]
Low
Report
Incyte marks late-stage trial win for Xencor-partnered lymphoma therapy [Seeking Alpha]